Evidence map›Paper›PMID 18830251›Full record

ArticleJournal of human hypertension2009

Peripheral arterial disease and isolated systolic hypertension: the ATTEST study.

M E Safar, P Priollet, F Luizy, J-J Mourad, P Cacoub, H Levesque, J Benelbaz, P Michon, M-A Herrmann, J Blacher

Abstract readComparative Study
PubMed Publisher
In one paragraph

Article in Journal of human hypertension, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
3.4field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 32 citations in OpenAlex.

  1. Review
  2. Article
  3. [Clinical characteristics and risk factors of lower extremity arterial disease in patients with diabetic foot ulcer].Nan fang yi ke da xue xue bao = Journal of Southern Medical University · 2022
    Article
  4. Observational
  5. Review
  6. Article
  7. Article
  8. Article
  9. β-blockade: benefits beyond blood pressure reduction?Journal of clinical hypertension (Greenwich, Conn.) · 2012
    Review
  10. Review
  11. Hypertension and peripheral arterial disease.Journal of human hypertension · 2009
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 7 institutions in 2 countries.

M E SafarFaculté de Médecine, Hôtel-Dieu hospital, Université Paris Descartes, Paris, France.
P Priollet
F Luizy
J-J Mourad
P Cacoub
H Levesque
J Benelbaz
P Michon
M-A Herrmann
J Blacher
Université Paris Cité · FRAssistance Publique – Hôpitaux de Paris · FRBristol-Myers Squibb (France) · FRPitié-Salpêtrière Hospital · FRSanofi (France) · FRSt. Joseph Hospital · USUniversité de Rouen Normandie · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hypertension is a risk factor for cardiovascular (CV) diseases, either coronary artery disease (CAD), peripheral artery disease (PAD) or cerebrovascular disease (CVD). The relationships between those different localizations of CV disease and the haemodynamic features of hypertension have been poorly evaluated in the past. In the ATTEST study, a geographically representative panel of 3020 general practitioners recruited 8316 consecutive patients with CV diseases (PAD, CAD or CVD, alone or in association). Blood pressure, which was not an inclusion criterion, was then measured and related to the different forms of CV diseases. Blood pressure classification involved 20% normotensive subjects, 24% subjects with controlled hypertension, 42% subjects with isolated systolic hypertension and 14% subjects with systolic-diastolic hypertension, all hypertensives with or without antihypertensive therapy. From multiple regression analysis, it appeared that subjects with systolic hypertension were characterized by the presence of PAD, with little or no presence of CAD and/or CVD. Subjects with systolic-diastolic hypertension were characterized by the presence of CAD and/or CVD, but without PAD. Although the former was only influenced by age, dyslipidaemia and diabetes mellitus influenced the latter. This study confirms the high prevalence of hypertension (80%) in a large population of patients with CV diseases selected in primary care. Analysis of different features of hypertension revealed that isolated systolic hypertension was the most prevalent form of hypertension in this treated population. Finally, one of the predominant goals of secondary prevention in subjects with PAD should be the treatment of isolated systolic hypertension.

Indexed as

AgedAntihypertensive AgentsBlood PressureCerebrovascular DisordersCoronary Artery DiseaseCross-Sectional StudiesFamily PracticeFranceHumansHypertensionMaleMiddle AgedPeripheral Vascular DiseasesPrevalencePrimary Health CareSecondary PreventionAntihypertensive Agents

Identifiers

PMID18830251
OpenAlexW2037556185

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.